Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
20 Februari 2026, 04:36:31
Role of Nutrition in COVID-19
Adequate nutrition is essential for optimal cellular function, particularly immune cells. During infection with COVID-19, the body enters a hyper-metabolic inflammatory state characterized by increased catabolism, oxidative stress, cytokine activation and accelerated protein breakdown. When dietary intake is insufficient, the body mobilizes endogenous stores (muscle protein, glycogen, fat, and micronutrient reserves), leading to:
Lean body mass loss
Immune dysfunction
Delayed recovery
Increased complications and mortality
Therefore, nutrition therapy is considered a core therapeutic intervention rather than supportive care alone.
TARGET POPULATION
This guidance applies to:
Infants and young children
Adolescents
Adults
Elderly
Pregnant and lactating mothers
Patients with chronic illnesses:
Hypertension
Diabetes mellitus
Cancer
Cardiovascular disease
Renal disease
A. PATHOPHYSIOLOGICAL EFFECTS OF COVID-19 ON NUTRITION
1. Hypermetabolism and Catabolism
Fever increases basal metabolic rate by ~10–13% per 1°C rise in temperature.
Consequences:
Rapid glycogen depletion
Lipolysis
Skeletal muscle proteolysis
Negative nitrogen balance
2. Micronutrient Depletion
Inflammation and oxidative stress cause increased consumption and urinary loss of:
Micronutrient | Function |
Zinc | Antiviral immunity |
Iron | Oxygen transport |
Folate | Cell division |
Vitamin A | Mucosal barrier integrity |
Vitamin C | Antioxidant & leukocyte function |
Vitamin E | Cellular protection |
3. Gastrointestinal Dysfunction
Cytokine effects impair digestion:
Reduced gastric emptying
Malabsorption
Nausea/vomiting
Diarrhea
Result: Reduced nutrient availability despite intake.
4. Fluid and Electrolyte Imbalance
Due to:
Fever
Sweating
Tachypnea
Diarrhea
Leads to:
Dehydration
Hypokalemia
Metabolic disturbances
5. Anorexia and Sensory Changes
Common symptoms:
Loss of smell (anosmia)
Loss of taste (ageusia)
Early satiety
Fatigue
→ Reduced caloric intake
B. GENERAL NUTRITIONAL RECOMMENDATIONS
Balanced Diet Composition
Patients should consume foods from all major food groups daily:
1. Energy Sources
Cereals, roots and tubers
Rice
Maize
Wheat
Cassava
Sweet potatoes
Yams
Plantains
Purpose: Prevent protein breakdown for energy
2. Protein Sources
Animal + plant proteins
Animal:
Meat
Fish
Eggs
Milk
Yogurt
Sardines
Plant:
Beans
Lentils
Cowpeas
Groundnuts
Sesame
Sunflower seeds
Purpose:
Antibody synthesis
Muscle preservation
Tissue repair
3. Vegetables
Examples:
Amaranth
Pumpkin leaves
Spinach
Okra
Carrots
Eggplant
Tomatoes
Provide:
Fiber
Folate
Antioxidants
4. Fruits
Vitamin-rich fruits:
Vitamin A | Vitamin C |
Mango | Guava |
Papaya | Citrus |
Pumpkin | Baobab |
Yellow fruits | Tamarind |
5. Fats and Oils
Vegetable oils
Coconut oil
Butter
Nuts
Purpose:
High-density calories
Anti-inflammatory fatty acids
C. SYMPTOM-SPECIFIC DIETARY MANAGEMENT
i. Fever
Goals: Hydration + energy preservation
≥8 glasses water/day
Oral rehydration fluids
High-protein small meals
Fruit juices
ii. Cough / Cold / Flu
Vitamin C rich fruits
Warm fluids
Ginger, garlic, turmeric
Green vegetables
iii. Sore Throat
Soft diet (porridge, mashed foods)
Warm foods
Avoid spicy & acidic foods
Saline gargles
iv. Nausea and Vomiting
Small frequent meals
Dry foods (crackers)
Avoid greasy foods
Do not lie immediately after meals
v. Loss of Taste or Smell
Flavor enhancers (herbs, spices)
Textured foods
Frequent meals
vi. Prevention of Anemia
Increase intake of:
Iron
Vitamin B12
Folate
Enhance absorption with vitamin CAvoid tea/coffee near meals.
D. FLUID MANAGEMENT
Fluid Overload (e.g., heart failure, renal disease)
Sodium restriction
Controlled fluid intake
Adjust potassium depending on diuretics
E. CO-MORBIDITY-SPECIFIC NUTRITION
Nutrition must be individualized for:
Condition | Key Consideration |
Diabetes | Glycemic control |
Renal disease | Protein & electrolyte restriction |
Cardiac disease | Sodium control |
Cancer | High protein high calorie |
F. NUTRITION IN CRITICALLY ILL PATIENTS
Critically ill patients frequently develop severe catabolism and may progress to Acute Respiratory Distress Syndrome requiring ICU admission.
1. Initial Assessment
Evaluate:
Recent weight loss
Muscle mass
Functional decline
Pre-ICU intake
2. Feeding Route Priority
Oral feeding (preferred)
Enteral nutrition (within 48 hrs)
Parenteral nutrition (3–7 days if needed)
3. Energy Targets
Early phase (Days 1–3):
≤70% energy needs
Stabilization (Days 3–7):
80–100% energy requirements
Purpose: Prevent overfeeding and refeeding syndrome
4. Protein Targets
High protein required to prevent muscle wasting.
5. Micronutrients
Provide daily:
Trace elements
Vitamins
Avoid high-dose antioxidant monotherapy unless deficiency proven.
6. When to Delay Enteral Feeding
Contraindications:
Uncontrolled shock
Severe hypoxemia
Severe acidosis
GI bleeding
High gastric residual (>500 ml)
Intestinal fistula
7. Special Considerations
Early enteral feeding improves survival
Avoid overfeeding
Monitor tolerance daily
KEY CLINICAL PRINCIPLE
Nutrition therapy is a disease-modifying treatment in COVID-19 — not merely supportive care.Early, adequate, and individualized nutrition significantly reduces complications, ICU stay, and mortality.
References
Ministry of Health, Community Development, Gender, Elderly and Children (United Republic of Tanzania). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. March 2021.
World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. WHO; 2020.
World Health Organization. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. WHO Interim Guidance; 2020.
World Health Organization. Coronavirus disease (COVID-19) Situation Report – 46. WHO; 2020.
Del Rio C, Malani PN. 2019 Novel Coronavirus—Important Information for Clinicians. JAMA. 2020;323(11):1039-1040.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of COVID-19 pneumonia in Wuhan, China. Lancet. 2020;395(10223):507-513.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China. Lancet. 2020;395:1054-1062.
Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020.
Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest Radiographic and CT Findings of COVID-19: Analysis of Nine Patients Treated in Korea. Korean J Radiol. 2020;21(4):494-500.
Peng QY, Wang XT, Zhang LN. Findings of lung ultrasonography of COVID-19 pneumonia. Intensive Care Med. 2020.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 compared with SARS-CoV-1. N Engl J Med. 2020;382:1564-1567.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign Guidelines on the Management of Critically Ill Adults with COVID-19. Crit Care Med. 2020.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526-2533.
Australian and New Zealand Intensive Care Society (ANZICS). COVID-19 Guidelines. Melbourne; 2020.
World Confederation for Physical Therapy. Physiotherapy management for COVID-19 (Version 1.0). 2020.
Queensland Health Clinical Excellence Division. COVID-19 Action Plan: Statewide General Medicine Clinical Network. 2020.
Imeandikwa:
24 Machi 2021, 19:36:10
